» Articles » PMID: 31367498

Postprandial Head-drops: Insight into Systemic Effects of Ocular Timolol Preparation in Elderly

Overview
Journal Cureus
Date 2019 Aug 2
PMID 31367498
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Timolol is a nonselective beta-adrenergic antagonist with no intrinsic sympathomimetic activity. Conditions like intraocular hypertension (IOH) and primary open angle glaucoma (POAG) warrant the use of a topical ocular preparation of timolol. It works to effectively lower the intraocular pressure (IOP) in patients with glaucoma but due to its unique pharmacodynamics, it also poses some very striking systemic side-effects. These include heart block, arrhythmias, and syncopal episodes. Herein, we present a challenging case of a previously known healthy elderly 67-year-old female, known case of POAG, who presented to the clinic with a very peculiar complaint, i.e. episodes of her head dropping down on to the table multiple times after she was done eating her food. This led to a cascade of diagnostic tests being employed encompassing cardiovascular, endocrinal, neurological, and gastrointestinal systems; all of which came out to be negative. Finally, after a very thorough literature review, it was established that timolol was the true culprit. The cessation of the drug immediately resulted in lasting relief.

Citing Articles

Timolol 0.5% ophthalmic solution influences cardiac function in healthy cats.

Tuleski G, Pscheidt M, Dos Santos J, Goncalves Sousa M J Feline Med Surg. 2022; 24(6):e57-e69.

PMID: 35470745 PMC: 11104227. DOI: 10.1177/1098612X221083372.

References
1.
Muller M, Van der Velde N, Krulder J, van der Cammen T . Syncope and falls due to timolol eye drops. BMJ. 2006; 332(7547):960-1. PMC: 1444852. DOI: 10.1136/bmj.332.7547.960. View

2.
Nieminen T, Lehtimaki T, Maenpaa J, Ropo A, Uusitalo H, Kahonen M . Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Scand J Clin Lab Invest. 2007; 67(2):237-45. DOI: 10.1080/00365510601034736. View

3.
Volotinen M, Hakkola J, Pelkonen O, Vapaatalo H, Maenpaa J . Metabolism of ophthalmic timolol: new aspects of an old drug. Basic Clin Pharmacol Toxicol. 2011; 108(5):297-303. DOI: 10.1111/j.1742-7843.2011.00694.x. View

4.
Walia H, Walia S, Emanuel M . Sick sinus syndrome associated with topical timolol maleate instillation. J Pharmacol Pharmacother. 2011; 2(4):300-2. PMC: 3198532. DOI: 10.4103/0976-500X.85946. View

5.
Pratt N, Ramsay E, Kalisch Ellett L, Nguyen T, Roughead E . Association between Ophthalmic Timolol and Hospitalisation for Bradycardia. J Ophthalmol. 2015; 2015:567387. PMC: 4385589. DOI: 10.1155/2015/567387. View